17.100
+4,91%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1755.6% | -743.0% | 1 / 3 | -26.8% | +1.01 pp | -4.64 pp | -1.8% | 0.59 | — | 42,2 | −26,8% | −1,9 | −1.755,6% | — | 66.95 | — |
| Pts | 0 | 0 | 4 | 0 | 8 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 17.100 (close price on 2026-10-19)EPS (TTM): −205,0
Financial charts
1.Revenue & growth
VND bn42,2Q2/26
1.Revenue & growth
VND bn42,2Q2/26
2.Profit & growth
VND bn-1,88Q2/26
3.Profit mix (Penman)
VND bn-0,46Q2/26
4.Margins & cost structure
%11.8%Q2/26
5.Returns & cash cycle
% · days-0.8%Q2/26
6.Earnings quality & cash
VND bn-7,85Q2/26
7.Asset structure
VND bn138Q2/26
8.Funding & debt health
VND bn · times138Q2/26
9.Revenue backlog
VND bn2,70Q2/26
10.Valuation
times · %-108,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-278Q2/26
Adjusted EPS growth, latest quarter
-1756%
Average adjusted EPS growth, 3 quarters
-1247%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26